LETTER TO THE EDITOR
Year : 2017 | Volume
: 12 | Issue : 3 | Page : 216--217
Role of pleural transthoracic ultrasound guidance
Maria Giulia Tinti1, Elisabettamaria Frongillo2, Marco Sperandeo2, 1 Department of Internal Medicine, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy 2 Department of Internal Medicine, Interventional Ultrasound Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy
Correspondence Address:
Maria Giulia Tinti Department of Internal Medicine, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG) Italy
How to cite this article:
Tinti MG, Frongillo E, Sperandeo M. Role of pleural transthoracic ultrasound guidance.Ann Thorac Med 2017;12:216-217
|
How to cite this URL:
Tinti MG, Frongillo E, Sperandeo M. Role of pleural transthoracic ultrasound guidance. Ann Thorac Med [serial online] 2017 [cited 2023 Mar 31 ];12:216-217
Available from: https://www.thoracicmedicine.org/text.asp?2017/12/3/216/210610 |
Full Text
Sir,
We read with interest the article by Ferreiro et al.,[1] recently published in your journal, focused on the correct management of pleural malignant effusions.
We absolutely agree that thoracentesis is one of the first approaches in pleural malignant effusions. However, procedure-related complications with transthoracic ultrasound (TUS) guidance are less frequent than reported in the review. We have performed 3870 drainages in the last 10 year with TUS guidance.[2] A diagnosis of malignant effusion was done in 630 patients (18%) with cytology on fluid samples. The rate of major complications was low: only four patients (0.1%) had iatrogenic pneumothorax (three showed partial pneumothorax and one subtotal pneumothorax; with full lung reexpansion in each case), and two patients had reexpansion lung edema.[2]
Under TUS guidance, it is also possible to determine the real-time characteristics of pleural effusion.[3] Indeed, accordingly to the US pattern of pleural effusion (anechoic, complex nonloculated, complex loculated, and homogeneously hyperechoic) [Figure 1], it is possible to choose the right needle size, i.e., generally an atraumatic 20-gauge and to use a low-flow and low-pressure aspiration system.[3] Moreover, it is advisable the use of dedicated probe, i.e., with a central hole through which the needle set is introduced.[4]{Figure 1}
One of the most relevant advantages of US guidance is the real-time needle visualization during the procedure.[4] In this way, the physician can retract the needle during lung reexpansion, avoiding pneumothorax, and hemothorax [Figure 2].{Figure 2}
TUS guidance is the primary procedure in the pleural fine needle aspiration biopsy (FNAB).[5] It allows us to perform a step-by-step FNAB with more ease and advantages in comparison with blind or computed tomography scan-guided biopsies.[5] Moreover, the FNAB-dedicated probes allow the physician to reach the lesion under the coaxial view, getting specimens of length, thickness, and quality adequate for pathology assessment.[5]
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
1 | Ferreiro L, Suárez-Antelo J, Valdés L. Pleural procedures in the management of malignant effusions. Ann Thorac Med 2017;12:3-10. |
2 | Sperandeo M, Catalano D, Melillo N, Foti T, Trovato GM. Transthoracic ultrasound for pleural effusion: Traps and tricks. Shortness Breath 2014;3:28-35. |
3 | Sperandeo M, Rotondo A, Guglielmi G, Catalano D, Feragalli B, Trovato GM. Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: Use and limitations. Radiol Med 2014;119:729-40. |
4 | Trovato GM, Sperandeo M, Catalano D. Thoracic ultrasound guidance for access to pleural, peritoneal, and pericardial space. Chest 2013;144:1735-6. |
5 | Sperandeo M, Dimitri L, Pirri C, Trovato FM, Catalano D, Trovato GM. Advantages of thoracic ultrasound-guided fine-needle aspiration biopsy in lung cancer and mesothelioma. Chest 2014;146:e178-9. |
|